Diversity of the T-cell response to pulmonary Cryptococcus neoformans infection

Infection and Immunity

Volumn 74, Issue 8, 2006, Pages 4538-4548

  Lindell, Dennis M ^a,b   Ballinger, Megan N ^a,b   McDonald, Roderick A ^a   Toews, Galen B ^a   Huffnagle, Gary B ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; MANNOPROTEIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR VBETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LYSATE; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; FEMALE; FUNGUS CULTURE; FUNGUS GROWTH; IMMUNOCOMPETENCE; LYMPHOCYTE PROLIFERATION; MOUSE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; SECONDARY IMMUNE RESPONSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; INTERFERON TYPE II; LUNG; LUNG DISEASES, FUNGAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED CBA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPLEEN; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746605600     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00080-06     Document Type: Article

References (26)

1. Acha-Orbea, H., and H. R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13:459-486.
2. + T cell responses. J. Immunol. 166:4627-4633.
3. Bentley, G. A., and R. A. Mariuzza. 1996. The structure of the T cell antigen receptor. Annu. Rev. Immunol. 14:563-590.
4. Busch, D. H., I. Pilip, and E. G. Pamer. 1998. Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection. J. Exp. Med. 188:61-70.
5. Casadevall, A., and J. R. Perfect. 1998. Cryptococcus neoformans. ASM Press, Washington, D.C.
6. Cibotti, R., J. P. Cabaniols, C. Pannetier, C. Delarbre, I. Vergnon, J. M. Kanellopoulos, and P. Kourilsky. 1994. Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J. Exp. Med. 180:861-872.
7. Cose, S. C., J. M. Kelly, and F. R. Carbone. 1995. Characterization of diverse primary herpes simplex virus type 1 gB-specific cytotoxic T-cell response showing a preferential V beta bias. J. Virol. 69:5849-5852.
8. Deckhut, A. M., W. Allan, A. McMickle, M. Eichelberger, M. A. Blackman. P. C. Doherty, and D. L. Woodland. 1993. Prominent usage of V beta 8.3 T cells in the H-2Db-restricted response to an influenza A virus nucleoprotein epitope. J. Immunol. 151:2658-2666.
9. + T cells are obligatory for vaccine-induced immunity to Histoplasma capsulatum. J. Immunol. 167:2219-2226.
10. Gomez, F. J., J. A. Cain, R. Gibbons, R. Allendoerfer, and G. S. Deepe, Jr. 1998. Vbeta4(+) T cells promote clearance of infection in murine pulmonary histoplasmosis. J. Clin. Investig. 102:984-995.
11. + T cells exert cooperative activity in clearance of secondary infection with Histoplasma capsulatum. J. Immunol. 166:2855-2862.
12. + T cell response to influenza virus infection. Cell. Immunol. 204:1-10.
13. + T cells. J. Exp. Med. 173:793-800.
14. Kedzierska, K., S. J. Turner, and P. C. Doherty. 2004. Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope. Proc. Natl. Acad. Sci. USA 101:4942-4947.
15. Kim, S. K., M. Cornberg, X. Z. Wang, H. D. Chen, L. K. Selin, and R. M. Welsh. 2005. Private specificities of CD8 T cell responses control patterns of heterologous immunity. J. Exp. Med. 201:523-533.
16. + cells in the periphery. Immunology 92:437-446.
17. Li, H., A. Llera, E. L. Malchiodi, and R. A. Mariuzza. 1999. The structural basis of T cell activation by superantigens. Annu. Rev. Immunol. 17:435-466.
18. + T cells during Cryptococcus neoformans infection. J. Immunol. 174:7920-7928.
19. Mansour, M. K., L. S. Schlesinger, and S. M. Levitz. 2002. Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. J. Immunol. 168:2872-2879.
20. Mody, C. H., K. L. Sims, C. J. Wood, R. M. Syme, J. C. Spurrell, and M. M. Sexton. 1996. Proteins in the cell wall and membrane of Cryptococcus neoformans stimulate lymphocytes from both adults and fetal cord blood to proliferate. Infect. Immun. 64:4811-4819.
21. Mody, C. H., C. J. Wood, R. M. Syme, and J. C. Spurrell. 1999. The cell wall and membrane of Cryptococcus neoformans possess a mitogen for human T lymphocytes. Infect. Immun. 67:936-941.
22. Orendi, J. M., A. F. Verheul, N. M. De Vos, M. R. Visser, H. Snippe, R. Cherniak, V. V. Vaishnav, G. T. Rijkers, and J. Verhoef. 1997. Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication. Clin. Exp. Immunol. 107:293-299.
23. + T cells. J. Immunol. 169:5818-5826.
24. Syme, R. M., J. C. Spurrell, L. L. Ma, F. H. Green, and C. H. Mody. 2000. Phagocytosis and protein processing are required for presentation of Cryptococcus neoformans mitogen to T lymphocytes. Infect. Immun. 68:6147-6153.
25. + human lymphocytes are activated and proliferate in response to Cryptococcus neoformans. Immunology 92:194-200.
26. + T cell response. Immunity 18:549-559.